
Amgen mourns death of George Rathmann, founding CEO
Biotech giant Amgen‘s (NSDQ:AMGN) founding CEO George Rathmann died this week at the age of 84. In his final years, Rathmann was a dialysis patient who took EPO, a red blood cell stimulating hormone he helped pioneer in Amgen’s early days. Read more
SeraCare names Charlie Mamrak CEO following close of merger with Linden Capital Partners